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Abstract
Background: Growth factors and their receptors are mediators of organogenesis and must be tightly regulated in a 
temporal and spatial manner for proper tissue morphogenesis. Intracellular regulators of growth factor signaling 
pathways provide an additional level of control. Members of the Sprouty family negatively regulate receptor tyrosine 
kinase pathways in several developmental contexts. To gain insight into the role of Spry1 in neural crest development, 
we analyzed the developmental effects of conditional expression of Spry1 in neural crest-derived tissues.
Results: Here we report that conditional expression of Spry1 in neural crest cells causes defects in craniofacial and 
cardiac development in mice. Spry1;Wnt1-Cre embryos die perinatally and exhibit facial clefting, cleft palate, cardiac 
and cranial nerve defects. These defects appear to be the result of decreased proliferation and increased apoptosis of 
neural crest and neural crest-derived cell populations. In addition, the domains of expression of several key 
transcription factors important to normal craniofacial and cardiac development including AP2, Msx2, Dlx5, and Dlx6 
were reduced in Spry1;Wnt1-Cre transgenic embryos.
Conclusion: Collectively, these data suggest that Spry1 is an important regulator of craniofacial and cardiac 
morphogenesis and perturbations in Spry1 levels may contribute to congenital disorders involving tissues of neural 
crest origin.
Background
Neural crest cells (NCC) are pleuripotent cells that
migrate out of the dorsal neural tube during early verte-
brate embryogenesis to populate many anatomical struc-
tures along the dorsoventral axis [1,2]. Cranial NCC
migrate ventrolaterally from the forebrain and hindbrain
region to populate craniofacial structures and branchial
arches. The proliferation of cranial NCC results in a
demarcation of each branchial arch. Once migration is
complete, cranial NCC contribute to the maxilla, mandi-
ble, cranial ganglia, and other mesenchymally derived
structures of the head and neck. Cardiac NCC emanating
from rhombomeres 6-8 populate branchial arches 3, 4,
and 6. Some cardiac NCC contributes to the development
of the branchial arch arteries, cardiac outflow tract, and
the spiral septum between the ascending aorta and the
main pulmonary artery. Other cardiac NCC contribute to
the formation of the outflow tract cushions/endocardial
cushions and subsequently the semilunar valves and
interventricular septum. Perturbations in normal neural
crest development cause several congenital craniofacial
and cardiac defects.
Cell-cell and tissue interactions are required for proper
patterning of neural crest-derived structures. Several
growth factors are important to NCC formation, migra-
tion, and differentiation, including members of the FGF
family and their receptors [1,2]. The identification of
mutations in fibroblast growth receptors (FGFRs) that
cause several craniosynostosis syndromes indicates a role
for FGF signaling in the skeletogenic differentiation of
NCC [3,4]. Furthermore, NCC proliferate, migrate, and
differentiate into cartilage and bone in vitro in response
to FGF2 [5,6]. In addition, tissue-specific deletion of
FGF8 demonstrated a requirement for FGF8 in NCC cell
survival and patterning of the first branchial arch [7]. A
hypomorphic allele of Fgfr1  has been used to demon-
strate that FGFR1 is required for NCC migration into the
second branchial arch [8]. Mice carrying this allele
showed severe abnormalities of the craniofacial bones
and cartilage. These and other studies show that FGF sig-
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naling is important to craniofacial development and that
gene dosage in components of the FGF pathway is impor-
tant to normal craniofacial development.
Sprouty (Spry) was originally identified in Drosophila
as a negative regulator of FGF signaling in tracheal devel-
opment [9]. Subsequently, Sprouty was demonstrated to
inhibit EGF signaling in Drosophila  eye development
[10,11]. In vertebrates, there are four Sprouty proteins
that either inhibit or potentiate receptor tyrosine kinase
(RTK) signaling in a context specific manner [12,13]. For
example, Spry2 can potentiate EGFR signaling by binding
to c-Cbl and sequestering it away from the EGFR, thus
preventing EGFR down regulation and degradation, con-
sequently leading to sustained EGFR activation, and
enhanced ERK signaling. Conversely, Spry2 inhibits ERK
activation mediated by FGFR signaling. Thus, Spry pro-
teins exhibit differential effects depending upon the cellu-
lar context.
During vertebrate development, Spry proteins exhibit
overlapping patterns of expression, particularly in cranio-
facial structures and limb buds [14]. Gene targeting stud-
ies have revealed both distinct and redundant functions
for Spry proteins during development. Targeted deletion
of Spry2 results in defects of inner ear and in tooth devel-
opment [15,16]. Deletion of Spry1 results in defects in
kidney development where supernumerary branching of
the ureteric buds occurs resulting in multiple ureters [17].
Spry4 null mice show defects in development of the man-
dible, polydactyly, and small size [18]. Mice that are null
for both Spry2 and Spry4 alleles exhibit very severe cran-
iofacial defects and dwarfism [18]. In addition, mice
homozygous for a 1 MB deletion of chromosome 14, a
region that encompasses the Spry2 gene, exhibited cleft
palate and cleft lip of variable penetrance [19]. Interest-
ingly, a mouse carrying a Spry2-BAC transgene rescued
the cleft palate defect. However, the Spry2-BAC trans-
genic line expressed Spry2 at reduced levels suggesting
that palate development is Spry2 dosage sensitive [19].
Due to the complex nature of Spry function and the pos-
sible redundancies during development, we developed a
conditional Spry1 transgenic mouse. To investigate the role
o f  S p r y 1  i n  r e g u l a t i n g  N C C  d u r i n g  d e v e l o p m e n t ,  w e
induced tissue-specific expression of Spry1 using Cre/loxP
recombination in the neural crest lineage by using Wnt1-
Cre  transgenic mice [20]. Our study shows that Spry1
expression in Wnt1-expressing neural crest cells in vivo
results in facial clefting, cleft plate, failure of formation of
the nasal and frontal bones as well as cardiovascular
defects including ventricular septal defects, and outflow
tract defects. Mutant embryos also exhibited hypoplastic
thyroid, thymus, and cranial ganglia. Spry1 expression in
NCC cells resulted in decreased proliferation and
increased apoptosis. We conclude that Spry1 is a regulator
of NCC cell proliferation and survival and that this occurs
in both NCC cells and NCC-derived mesodermal cells that
result in craniofacial and cardiac structures.
Results
Spry1 is expressed in migrating and post-migratory neural 
crest cells
We examined the expression Spry1 in mouse embryos
from E8.0 to E10.0 using whole-mount in situ hybridiza-
tion. In situ hybridization analysis at E8.0 revealed that
Spry1 is highly expressed in the cranial neural folds and
presomitic mesoderm (Figure 1A) and continues to be
expressed in regions populated by cells of neural crest
origin including the branchial arches 1, 2, and 3, the fron-
tonasal process, the midbrain hindbrain boundary, as well
as limb buds and presomitic mesoderm at E9.0 (Figure
1C). This pattern persists until about E10.0 (Figure 1E,F).
These expression data are consistent with a previous
report [14]. To gain additional insight into the pattern of
embryonic Spry1 expression, we performed β-gal staining
on Spry1lacZ/+ embryos at E8.5. A coronal section through
the rostral region indicates β-gal staining in the presump-
tive neural crest (Figure 1H, I black arrowhead) as well as
the underlying mesoderm (Figure 1I, red arrow).
Conditional expression of Spry1 in neural crest cells
In situ hybridization and β-gal staining patterns of Spry1
suggests that it plays a role in the development neural
Figure 1 The whole mount expression pattern of Spry1 in develop-
ing mouse embryos. (A) E8.0, (B) E8.5, (C) E9.0, (D) E9.5 and (E, F) E10. 
Spry1 is expressed in the primitive streak, brachial arches, midbrain-hind-
brain boundary, lateral mesoderm and tail bud. E8.5 Spry1+/-LacZ em-
bryos were stained with β-gal and sectioned through the plane 
indicated (G). β-gal staining is evident in the presumptive neural crest (H, 
arrowheads indicate the neural folds) and higher magnification (I).Yang et al. BMC Developmental Biology 2010, 10:48
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crest derived sutures. To investigate this further we used
transgenic mice with a floxed mSpry1 transgene, which
efficiently undergoes Cre-mediated recombination as we
have previously demonstrated [21]. To enable tissue spe-
c i f i c  e x p r e s s i o n  i n  n e u r a l  c r e s t ,  w e  c r o s s e d  CAGGFP-
Spry1 transgenic females with male Wnt1-Cre transgenic
mice. Bitransgenic mouse embryos were designated
Spry1;Wnt1-Cre and were confirmed by genotyping for
GFP and Cre by PCR [21]. Littermates carrying the Spry1
transgene, but lacking the Wnt1-Cre transgene served as
controls in these studies. All Spry1;Wnt1-Cre  mutant
embryos died at birth and exhibited severe craniofacial
defects (data not shown). Prenatal lethality was not
observed. Attempts to show transgenic protein expres-
sion by immunohistochemistry proved difficult due to
issues of sensitivity and background of the anti-myc anti-
body used to detect the epitope tagged transgenic pro-
tein. However, we have previously demonstrated Spry1
transgenic protein expression using the same transgenic
mice when crossed with other transgenic Cre driver
strains [21]. qPCR analysis revealed expression levels of
the transgene to be 2-8 fold above endogenous expression
levels (Yang, data not shown).
Spry1;Wnt1-Cre embryos exhibit craniofacial defects
Severe facial clefting was detected at E16.5 in
Spry1;Wnt1-Cre embryos but not their Cre-negative lit-
termates (Figure 2A-C). Skeletal preparations of E16.5
Spry1;Wnt1-Cre embryos revealed hypoplastic and mal-
formed bones and cartilage of the head (Figure 2D, E) and
neck (data not shown). The maxilla was incomplete and
malformed (Figure 2E) and the mandible was smaller
(Figure 2F). Skeletal preparations of E18.5 Spry1;Wnt1-
Cre embryos reveals a complete absence of the frontal
and nasal bones, whereas the parietal, interparietal and
occipital bones that are not derived from neural crest,
formed normally (Figure 2G, H). In addition, the premax-
illa and maxilla were malformed or absent and the zygo-
matic arch was poorly developed. Defects in development
were also detected by MRI at E14 and included in addi-
tion to the externally visible craniofacial defects, but also
defects in cardiac development including dilatation of
cardiac chambers and an outflow tract defect (Figure 2I).
Conditional expression of Spry1 inhibits palatogenesis
The failure of fusion of the secondary palate of
Spry1;Wnt1-Cre embryos was evident by E14.5 when Cre-
negative littermate controls showed normal fusion of the
palatal shelves (Figure 3A, B). We compared cross-sections
of E16.5 Spry1;Wnt1-Cre  mutant embryonic heads with
Cre-negative littermate control embryos. At E16.5 there
was a failure of the elevation of the palatal shelved in
Spry1;Wnt1-Cre embryos (Figure 3D, F, and 3H), while the
Cre-negative control littermates showed elevation and
fusion of the palatal shelves (Figure 3C, E, and 3G).
Conditional expression Spry1 inhibits proliferation and 
increases apoptosis in neural crest and neural crest-derived 
structures
To gain insight into the possible mechanisms that con-
tribute to the craniofacial defects observed in
Spry1;Wnt1-Cre  embryos we crossed the conditional
CAGGFP-Spry1  mice with R26R;Wnt1-Cre  transgenic
mice to generate Spry1;R26R;Wnt1-Cre mutant embryos.
Whole-mount β-gal staining (Figure 4A-D) and sections
(Figure 4E-H) through E10.5 Spry1;R26R;Wnt1-Cre
embryos revealed β-gal positive cells remained in the
dorsal neural tube of both Spry1;R26R:Wnt1-Cre  and
R26R;Wnt1-Cre embryos at this stage even though most
cranial neural crest cells have emigrated from this region.
In addition, the branchial arches of Spry1;R26R:Wnt1-Cre
embryos were smaller than that of the R26R;Wnt1-Cre
control embryos, however β-gal-positive cells were pres-
ent (Figure 4E-H). The distribution of β-gal-positive cells
was also altered in Spry1;R26R;Wnt1-Cre embryos with
reduced mesenchymal cells underlying the β-gal-positive
cells. There was also reduced β-gal staining in the trunk
of  Spry1;R26R;Wnt1-Cre  embryos (Figure 4C, D red
arrows). Therefore, to investigate a possible mechanism
responsible for facial clefting and mandibular hypoplasia,
we investigated whether there were changes in cell prolif-
eration or apoptosis that would account for the observed
craniofacial defects. Cell proliferation as measure by
phospho-histone H3 immunostaining, was reduced
approximately 2-fold in the neural tube of E10.5
Spry1;Wnt1-Cre  mutant embryos when compared to
their littermate controls (Figure 5B, D). In addition, pro-
liferation was reduced in the branchial arches of E10.5
Spry1;Wnt1-Cre  embryos when compared to littermate
controls in regions of both NCC-derived and underlying
mesodermal cells (Figure 5C, D). We also investigated the
possibility that apoptosis may have contributed to the
defects observed in Spry1;Wnt1-Cre  mutant embryos.
For programmed cell death analysis, TUNEL staining was
performed on sections of E10.5 embryos. Significant
TUNEL staining was detected in sections through the
anterior neural tube of Spry1;Wnt1-Cre mutant embryos,
but not in similar sections from Cre-negative control lit-
termates (Figure F,G,H). Together these data are consis-
tent with the reduced pattern β-gal staining in
Spry1;R26R;Wnt1-Cre embryos and suggest that induced
Spry1 expression in Wnt1-expressing cell populations
inhibits proliferation and increases apoptosis contribut-
ing to the anatomical defects.
Forced expression of Spry1 in transgenic mouse embryos 
decreases the expression domains of craniofacial marker 
genes
The proliferation, migration and differentiation of NCC
are regulated by growth factor signaling pathways and
downstream transcription factors. To investigate theYang et al. BMC Developmental Biology 2010, 10:48
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effect of forced expression of Spry1 on the expression of
genes crucial to craniofacial development and NCC dif-
ferentiation we performed whole mount in situ hybrid-
ization on E10.5 Spry1;Wnt1-Cre  embryos and their
control littermates. AP2α is expressed in the neural crest
cells of the dorsal neural tube during mammalian devel-
opment [22]. We first examined AP2α expression in E10.5
Spry1;Wnt1-Cre embryos as we reasoned that expression
Figure 2 Spry1;Wnt1-Cre embryos exhibit craniofacial defects. (A-C) E16.5 embryo imagines, (A) Lateral view of whole embryos (from original 1×), 
(B) frontal and (C) lateral views of head (from original 2.5 ×) shows facial clefting in Spry1;Wnt1-Cre (Spry1) embryos. (D-H) Skeletal preparations of E16.5 
embryos stained by alcian blue and alizarin red, (D) lateral and (E) basal views, the mandibles were removed to enhance the view of the of cranial base, 
arrows indicate absent bones or abnormal elements. (F) The mandible was shorter in Spry1;Wnt1-Cre embryos compared to WT controls. (G-H) Skeletal 
preparations of newborn mice, (G) dorsal and (H) basal views. Data presented are representative of five litters analyzed at this gestational age. Na: nasal 
capsule; nb: nasal bone; fn: front bone; bs: basisphenoid; eo: exooccipital; ip: interparietal bone; mx maxilla; md: mandible; ob: basioccipital; pa: parietal 
bone; ps: presphenoid; so: supraoccipital. (I) In utero MR images of WT and Spry1;Wnt1-Cre embryos at 14 dpc. The overview image shows 4 embryos 
in varying orientations and views. The enlarged view on the right side show (top) a WT embryo with normal facial and cardiac development and (bot-
tom) a Spry1;Wnt1-Cre embryo with severe facial malformations, enlarged heart and defective cardiac outflow tract. Images were obtained with a RARE 
pulse sequence (TE 39.8 ms, TR 2571 ms, FOV 35 × 35 mm, matrix 256 × 256, slice thickness 1 mm (total of 7 slices), 3 averages, total scan time 4 min. 
6 sec).Yang et al. BMC Developmental Biology 2010, 10:48
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of  AP2α  may be affected because Spry1;Wnt1-Cre
embryos exhibited several abnormalities in common with
AP2α-/-  embryos. Whole mount in situ hybridization
revealed that AP2α  expression was greatly reduced in
Spry1;Wnt1-Cre embryos compared to their control litter
mates (Figure 6A and 6B). We next examined the expres-
sion of Msx1  and  Msx2  in  Spry1;Wnt1-Cre  embryos.
Mice that are homozygous null for both Msx1 and Msx2
exhibit severe craniofacial dysmorphology and a com-
plete absence of the frontal bone [23]. Spry1;Wnt1-Cre
embryos also exhibit a complete absence of the frontal
bone; therefore we surmised that Msx1 and Msx2 expres-
sion would be reduced or absent. Our data indicate that
forced expression of Spry1 in Wnt1-Cre expressing cells
results in reduced domains of Msx1 and Msx2 expression
in craniofacial structures, while expression in the limb
buds remains intact albeit at a reduced level.
The homeobox genes Dlx5 and Dlx6 play important
roles in craniofacial and limb development [24]. Mice
that are null for both Dlx5 and Dlx6 exhibit severe cran-
iofacial, axial, and appendicular skeletal abnormalities,
resulting in perinatal lethality. Whole mount in situ
hybridization of E10.5 Spry1;Wnt1-Cre  embryos show
that domains of expression of Dlx5 in the first and second
branchial arches are greatly reduced. Similarly, Dlx6
expression domains were reduced in the first and second
branchial arches. Dlx5 and Dlx6 expression in the limbs
was variable but often reduced.
Fgf8 expression is maintained in Spry1-expressing 
transgenic mice
FGFs and in particular fgf8 play an important role in neu-
ral crest development. Fgf8 expression in the ectoderm of
the first and second branchial arch is induced by Shh sig-
nals from the foregut endoderm [7,25-27]. The branchial
arch ectoderm-derived fgf8 in turn regulates the prolifer-
ation and differentiation of post-migratory NCC. To
determine whether fgf8 expression was altered in
Spry1;Wnt1-Cre embryos through a cell non-autonomous
mechanism, we performed whole mount in situ hybrid-
ization with an fgf8 riboprobe (Figure 7). These data indi-
cate that fgf8 expression remains intact in E10.5
Spry1;Wnt-Cre  embryos when compared to their litter
Figure 3 Spry1;Wnt1-Cre embryos exhibit cleft palate. (A, B) The 
developing mandible and tongue were removed from E14.5 embryos 
to show the developing medial epithelial seam of the palatal shelves 
in WT but not in Spry1;Wnt1-Cre (Spry1) embryos (dash line indicated), 
(C-H) cross sections of E16.5 embryo heads stained with hematoxylin 
and eosin. (C, D) Low magnification shows the fused palate and the 
separated nasopharynx and oral cavity in WT control, but not in 
Spry1;Wnt1-Cre embryos (from original 10 ×), (E, F) high magnification 
from the boxed areas in C and D (from original 10 ×), (G, H) high mag-
nification from the boxed areas of E and F (from original 20 ×). OC: oral 
cavity; PS: palatal shelves; T: tongue. Data are representative of four lit-
ters analyzed as this stage.
Figure 4 Spry1;Wnt1-Cre embryos have reduced β-gal staining in 
neural crest-derived structures. (A-D) Whole mount β-gal staining, 
(A, B) lateral view to show neural crest cells (blue) have contributed to 
the branchial arches and lateral mesoderm both in Spry1;Wnt1-Cre 
(Spry1) and WT control mice, however the β-gal stained neural crest 
derivatives in Spry1 embryos were smaller than those of the controls 
(WT) (arrows indicated). (C, D) Dorsal view to show the similar intensity 
of β-gal staining at the ridge of the neural tube of R26R;Wnt1-Cre (WT) 
or Spry1;R26R;Wnt1-Cre embryos. (E-H) Cross sections of E9.5 whole 
mount β-gal stained embryos. (E, F) Low magnification to show inten-
sity of β-gal staining in ridge of neural tube and brachial arches of WT 
and Spry1;Wnt1-Cre embryos. (G, H) High magnification to show the 
decreased cellular mass in the first branchial arch of Spry1;Wnt1-Cre 
embryos with reduced β-gal staining. Data are representative of three 
independent experiments.Yang et al. BMC Developmental Biology 2010, 10:48
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mate controls. Although there are some differences in the
size and shape of the nasal placodes, the first branchial
arch and isthmus of the midbrain-hindbrain boundary,
the intensity of the fgf8 signal is similar between
Spry1;Wnt1-Cre and control embryos. This data rules out
the possibility that changes in fgf8 expression or availabil-
ity account for the decrease in proliferation seen in the
first arch of Spry1;Wnt1-Cre embryos (Figure 5C).
Spry1;Wnt1-Cre embryos have cranial nerve patterning 
defects
NCC derived from rhombomeres 2, 4, 6, and 7 contribute
to the formation of the cranial nerves [22,28]. To deter-
mine the effect of conditional expression of Spry1 in
Wnt1-Cre expressing cells on cranial nerve morphogene-
sis, E10.5 Spry1;Wnt1-Cre embryos were immunostained
with a neurofilament-M antibody. Results reveal abnor-
malities in several cranial nerves, with the most severe
defects in cranial nerves IX (glossopharyngeal) and X
(vagus) (Figure 8A and 8B). In Spry1;Wnt1-Cre embryos
there is a disruption of branching of cranial nerves IX and
X and a displacement from their normal position (Figure
8B). To determine whether these defects persist at later
stages of development we performed H&E staining on
sections of E16.5 Spry1;Wnt1-Cre embryos and their Cre-
negative littermates. Transverse sections posterior to the
otic placode reveals severe hypoplasia of dorsal root gan-
glia (Figure 8C and 8D).
Cardiovascular malformations in Spry1;Wnt1-Cre 
transgenic mice
MRI imaging of E14 embryos (Figure 2) prompted us to
examine the hearts of E18.5 and E14.5 Spry1;Wnt1-Cre
embryos. These analyses revealed outflow tract malfor-
mations including a persistent truncus arteriosus and
double outflow right ventricle (DORV) and their associ-
ated cardiac defects (Figure 9). Histological examination
of these hearts revealed failure of the outflow tract to sep-
tate into two distinct outflows resulting in a persistent
truncus arteriosus. The truncus, which overrode the
Figure 5 Overexpression of Spry1 in neural crest-derived cells in-
duced apoptosis and reduced cell proliferation. (A-D) Phospho-his-
tone H3 immunofluorescence staining of E10.5 embryo cross sections 
showed the reduced phospho-histone H3 positive cells in Spry1;Wnt-
Cre (Spry1) embryos compared to Cre-negative littermate controls(WT) 
(from original 40×). Low magnification to show similarity of sections 
(from original 10×) (A), high magnification to show the decreased 
phospho-histone H3 positive cells in neural tube (B) and branchial 
arches (C) of Spry1;Wnt1-Cre mice compared to WT control (from orig-
inal 40×). (D) Quantification of phospho-histone H3 positive cells. (E-G) 
TUNEL labeling shows an increase in apoptotic cells in the neural tube 
of Spry1;Wnt1-Cre embryos but not in control embryos (from original 
40×). (H) Quantification of TUNEL labeled cells. NT: neural tube; BA: 
branchial arch. Data shown are representative of three independent 
experiments.
Figure 6 Overexpression of Spry1 in neural crest cells decreased 
expression of craniofacial marker genes at E10.5. (A, B) Overexpres-
sion of Spry1 decreases the expression domains of AP2α, Msx1 and 
Msx2 expression. (A) Lateral view to show the decreased expression of 
AP2α, Msx1 and Msx2 in the branchial arches of Spry1;Wnt1-Cre (Spry1) 
embryos, (B) frontal view to show the decreased expression of AP2α, 
Msx1 and Msx2 in maxilla and nasal pits of Spry1;Wnt1-Cre embryos. (C, 
D) Overexpression of Spry1 reduced expression domains of Dlx5 and 
Dlx6. (C) Lateral view to show the decreased expression of Dlx5 and 
Dlx6 in branchial arches of Spry1;Wnt1-Cre embryos. (D) Frontal view to 
show the decreased expression domains of Dlx5 and Dlx6 in maxilla 
and nasal pits of Spry1;Wnt1-Cre embryos compared to control (WT) 
mice. All in situ hybridization experiments were performed at least 
three times on Spry1;Wnt1-Cre embryos and their Cre-negative litter-
mates. Color development time was equivalent for each experiment.Yang et al. BMC Developmental Biology 2010, 10:48
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interventricular septum, had only one valvular structure
with three leaflets and there was an associated membra-
nous ventricular septal defect (VSD). The pulmonary
trunk arose just distal the truncal valve on the left lateral
side. The right ventricular outflow tract connection to the
truncus was shifted to the right and pointed towards the
midline in comparison to the WT in which the flow was
directed towards the left side. The left ventricular outflow
tract connected into the truncus in a similar configura-
tion with the WT with the direction of flow pointing
towards with a right. In Figure 9F, a DORV was the result
of a malrotated/malaligned heart with a dextroposed
aorta arising off the right ventricle with an associated
membranous VSD. In addition, the pulmonary outflow
tract was narrowed with a stenotic hypoplastic pulmo-
nary valve, which lacked distinct leaflets. The pulmonary
trunk connected to a patent ductus arteriosus ensuring
an adequate blood supply to the pulmonary circulation
via the aorta. In addition, there were observed aortic arch
anomalies in these hearts as seen in Figure 9B; no distinct
left subclavian artery was visualized.
To analyze neural crest contributions to cardiac devel-
opment in Spry1;Wnt1-Cre embryos, we examined histo-
logical sections taken from whole mount E9.5
Spry1:R26R;Wnt1-Cre embryos or R26R;Wnt-Cre litter-
mates (Figure 10). Presumptive NCC marked by β-Gal
staining in Figure 10A showed strong staining in the
branchial arches and the outflow tract of control
embryos. In contrast, Spry1;R26R;Wnt1-Cre  embryos
(Figure 10B) showed variable staining in the branchial
arches and greatly diminished staining in the outflow
tract. Histological sections (Figure 10C-F) revealed the
first branchial arch was hypoplastic in the mutant vs. the
control. The control embryos showed β-gal positive NCC
colonizing the cardiac mesenchyme throughout the out-
flow tract and down into the bulbis cordis (Figure 10C,
E). The mutant showed a paucity of β-gal positive neural
crest cells colonizing the cardiac mesenchyme with a near
total absence in the bulbis cordis. The outflow tract of the
mutant was shortened and poorly rotated in comparison
to the WT, which was elongated with a more spiral con-
figuration. The lack of sufficient numbers of β-gal posi-
tive NCC colonizing the cardiac mesenchyme resulted in
abnormal cardiac morphogenesis with the failure of the
outflow tract to elongate normally, undergo normal car-
diac looping, which as a consequence altered the rotation,
alignment and septation of the outflow tract. Septation
most likely did not occur due to the failure of the forma-
tion of the aorticopulmonary septum whose formation is
critically dependent upon sufficient numbers of cardiac
NCC colonizing and proliferating in the cardiac mesen-
chyme. DORV was a consequence of the malrotation and
malalignment of the outflow tract, which was not posi-
tioned into its normal configuration between the atrio-
ventricular valves. Cardiac NCC, in conjunction with the
cells of the primary and secondary heart fields, are essen-
tial for normal formation of the endocardial cushions and
conotruncal cushions. Deficiencies in these structures,
which are dependant on cardiac NCC proliferation, sig-
naling and interaction with the primary and secondary
heart field cells, most likely led to the observed cardiac
defects.
Discussion
Our previous studies have revealed an important role for
Spry1 in endochondral bone formation and chondrogen-
esis [21]. We undertook the present study to determine
the role of Spry1 in craniofacial development. Previous
studies using gene-targeting strategies revealed that tar-
geted deletion of Spry1 [17] did not produce a craniofa-
cial phenotype, and deletion of Spry2 produced defects in
the inner ear [15] and dentition [16], however deletion of
Spry2 and Spry4 results in several abnormalities includ-
ing facial clefting and limb defects [18]. In furtherance of
these studies, we used Spry1 transgenic mice to gain addi-
tional insight into the role of Spry1 in craniofacial devel-
opment. To gain insight into the role of Spry1 in
development of NCC-derived structures, we used a
floxed transgenic allele of Spry1  [21], and induced its
expression in NCC by Cre-mediated recombination
Figure 7 fgf8 expression is unaffected in Spry1;Wnt1-Cre embry-
os. (A) Lateral view and (B) frontal view to show the similarity in pattern 
and intensity of fgf8 expression in both WT and Spry1Wnt1-Cre (Spry1) 
E10.5 embryos. (C) Dorsal view showing the similarity of expression of 
fgf8 in otic placode both in WT and Spry1;Wnt1-Cre embryos, however 
overexpression of Spry1 resulted in a reduced and abnormal midbrain-
hindbrain boundary. Data are representative of three independent ex-
periments.Yang et al. BMC Developmental Biology 2010, 10:48
http://www.biomedcentral.com/1471-213X/10/48
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driven by the Wnt1 promoter [20]. Mutant embryos died
perinatally from multiple defects including severe facial
clefting and cardiovascular defects including persistent
truncus arteriosus and ventricular septation defects. We
also observed hypoplasia of the thymus and thyroid
glands (Kilgallen and Friesel, data not shown). Our results
with Spry1;Wnt1-Cre embryos are consistent with insuf-
ficient neural crest-derived cells populations for normal
craniofacial and cardiac morphogenesis. Our data indi-
cate that increased apoptosis and decreased cell prolifera-
tion likely cause the NCC insufficiency. Although our
analysis was performed at an embryonic stage where
most cranial neural crest have emigrated from the neural
tube, Wnt1-Cre mediated β-gal staining was still evident
Figure 8 Impaired cranial nerve development in Spry1;Wnt1-Cre embryos. (A) Whole mount staining with neurofilament antibody at E10.5 
shows smaller nerve filament bundles in Spry1Wnt1-Cre (Spry1) embyos compared to Cre-negative littermate controls (WT). (B) Higher magnification 
to show the defect in cranial nerves IX and X in Spry1;Wnt1-Cre transgenic embryos (* indicates misplaced cranial nerves). (C, D) Hematoxylin and eosin 
staining of E16.5 cross sections to show the smaller dorsal root ganglia in Spry1;Wnt1-Cre embryos compared to littermate controls (arrow indicated). 
(D) High magnification from boxed areas in C. IX: glossopharyngeal nerve; X: vagus nerve. Six Spry1;Wnt1-Cre and six control embryos representing 
two litters were analyzed.Yang et al. BMC Developmental Biology 2010, 10:48
http://www.biomedcentral.com/1471-213X/10/48
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in  Spry1;R26R;Wnt1-Cre  embryos in the dorsal neural
tube at this stage. This suggests that some residual neural
crest cells or neural crest-derived cells remained in this
region suggesting that decreased proliferation and
increased apoptosis in the dorsal neural tube may be
attributable to this population of β-gal positive cells.
In Spry1;R26R;Wnt1-Cre transgenic embryos β-gal pos-
itive cells were present in the branchial arches, and the
cardiac region, however the number of β-gal positive
cells, and the overall size of the branchial arches and neu-
ral crest-derived cardiac structures was greatly reduced.
Immunostaining for phospho-histone H3, a marker of
proliferation, and TUNEL assays revealed decreased pro-
liferation and increased apoptosis respectively in the
branchial arches of Spy1;Wnt1-Cre embryos but not their
Cre-negative littermates suggesting that the increase in
NCC apoptosis is a contributor to the observed craniofa-
cial defects. Because fgf8 expression was essentially nor-
mal in Spry1;Wnt1-Cre embryos, fgf8 availability is likely
not a factor in decreased NCC survival. Furthermore, we
cannot rule out the possibility that the β-gal positive cells
in the branchial arches and outflow tract did not undergo
recombination of the Spry1 transgene, which may
account for the β-gal positive cells that are present in this
region. However, the increase in apoptosis and decrease
in proliferation in this region suggest that Spry1 expres-
sion affected development of these structures possibly by
affecting the reciprocal signaling between the NCC-
derived mesoderm and the overlying ectoderm.
Figure 9 Spry1;Wnt1-Cre embryos exhibit cardiac outflow tract 
malformations and associated cardiac defects. (A, B) Cre-negative 
littermate control (WT) and Spry1;Wnt1-Cre (Spry1) embryos at E18.5; 
gross photos of heart. A, shows WT with normal outflow tract and aor-
tic arch architecture, and B shows abnormal outflow tract architecture 
with a persistent truncus arteriosus (TA) and aortic arch anomalies. (C, 
D) WT and Spry1;Wnt1-Cre E18.5 embryos, coronal sections through the 
thoracic cage stained with H&E. (C) normal outflow tract with aortic 
valve (AV) and pulmonary valve (PV) and an intact interventricular sep-
tum (black arrow). (D) Spry1;Wnt1-Cre enbryo shows a persistent trun-
cus arteriosus (TA) which overrides the interventricular septum (IS) 
with a membranous ventricular septal defect (black arrowhead). (E, F) 
WT control and Spry1;Wnt1-Cre E14.5 embryos sectioned through the 
thoracic cage. (E) WT normal cardiac architecture. (White arrow de-
notes left ventricular outflow). (F) Shows a double outflow right ventri-
cle with the aorta (Ao) arising from the right ventricle (white 
arrowhead) and the pulmonary outflow tract, which is narrowed with 
a malformed pulmonary valve and ventricular septal defect (not 
shown). LV-left ventricle, RV-right ventricle, RA-right atrium, LA-left atri-
um, Ao-aorta, PT-pulmonary trunk, DA-dorsal aorta, TA-truncus arterio-
sus, Aa-aortic arch, PV-pulmonary valve, AV-aortic valve, BC-
brachiocephalic artery, LC-left common carotid artery, LS-left subclavi-
an artery, Asterix *-ductus arteriosus. Data are representative of six em-
bryos from each group (WT and Spry1) from two independent litters.
Figure 10 Spry1;Wnt1-Cre embryos show outflow tract defects at 
E9.5. (A, B) Whole mount β-gal staining of Cre-negative littermate con-
trol and Spry1;Wnt1-Cre E9.5 embryos. (A) WT shows intense β-gal 
staining of the outflow tract (white arrow) and branchial arches, indi-
cating cells of NC origin. (B) Spry1;Wnt1-Cre E9.5 embryo, shows vari-
able β-gal staining of the pharyngeal arches and reduced staining of 
the outflow tract (white arrowhead). (C, D) Sagittal sections of whole 
mount embryos with nuclear fast red counter-staining. (C) WT shows 
normal distribution of cardiac NCC within the outflow tract, with β-ga-
lactosidase positive NCC cells extending down to the bulbis cordis. 
Panel D, Spry1;Wnt1-Cre reveals outflow tract with reduced β-galacto-
sidase positive NCC cells. In addition the first branchial arch, mandibu-
lar component, is greatly reduced in size relative to the WT. The 
outflow tract in Spry1;Wnt1-Cre embryos is shortened and does not 
adopt the spiral configuration as seen in the WT. (E,F) High power im-
ages of C,D; white boxed areas indicate field of view. (E) WT, black ar-
row indicates cardiac NCC contributing cardiac mesenchyme. (F) 
Spry1;Wnt1-Cre embryo, black arrowhead notes paucity of NCC in car-
diac mesenchyme. FBA: first branchial arch, mandibular component. 
Data are representative of six embryos from each group.Yang et al. BMC Developmental Biology 2010, 10:48
http://www.biomedcentral.com/1471-213X/10/48
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Palate development is a multistep process that involves
the growth, elevation and midline fusion of the palatal
shelves. The palatal shelves are comprised of NCC-derived
ectomesenchyme and pharyngeal ectoderm [1,20,29]. The
growth and development of the palate is controlled by sev-
eral growth factors including members of the TGF-β fam-
ily and members of the FGF family. Conditional loss-of-
function of Tgfbr2 in NCC of Tgfbr2fl/fl; Wnt1-Cre mutant
mice results in cleft palate [29]. Mice carrying a large dele-
tion of chromosome 14 (Pub36-/-), a region that contains
the Spry2 gene exhibit cleft palate, excessive cell prolifera-
tion and up regulation of FGF target genes including Msx1,
Etv5 and Barx1 [19]. Interestingly, targeted disruption of
Spry2 did not phenocopy the megabase deletion in chro-
mosome 14; however a BAC Spry2 transgene expressing
reduced levels of Spry2 completely rescued the facial cleft-
ing and cleft palate phenotype in Pub36-/-  mice [19].
These data suggest that palate development is sensitive to
Spry2  gene dosage. Our data are consistent with this
notion.  Spry1  and  Spry2  have overlapping domains of
expression during development and current data suggest
that they may be functionally redundant in regulating FGF
signaling [13]. Here we show that Spry1 over expression in
neural crest derivatives partially phenocopies the palate
defect of the Pub36-/- mutation. Together, these data sug-
gest that normal palate development is in part dependent
upon proper growth factor signaling thresholds, and that
Spry1 and Spry2 play a key role in regulating these thresh-
olds. Whether the roles of Spry1 and Spry2 are functionally
redundant in palate development remains to be deter-
mined using tissue-specific loss-of-function approaches
targeting two or more Spry family members in neural crest
in vivo.
In addition to controlling palate development, TGFβ
receptors and tyrosine kinase receptors (RTK) regulate
the development of the calvarial bones of the skull that
are derived from NCC [1,6,30-32]. Spry1;Wnt1-Cre mice
show craniofacial and cardiac phenotypes that are very
similar to Pdgfrαfl/fl; Wnt1-Cre embryos including facial
clefting, and aortic arch defects [30]. The similarity in
phenotypes between a loss-of-function Pdgfrα  mutant
and a gain-of-function Spry1 mutant are consistent with
the notion that Spry 1 inhibits signaling downstream of
RTKs. While the phenotypes of Spry1;Wnt1-Cre and Pdg-
frαfl/fl; Wnt1-Cre  embryos are similar, Pdgfrαfl/fl; Wnt1-
Cre embryos did not show any changes in proliferation or
apoptosis and the authors speculated that the defects
were due to defects in NCC differentiation [30]. Con-
versely, Spry1;Wnt1-Cre embryos showed decreased pro-
liferation and increased apoptosis in NNC derived
structures. While it is likely that increased proliferation
and decreased apoptosis in NCC of Spry1;Wnt1-Cre
embryos contributes to the phenotype, it is also possible
that similar to the Pdgfrαfl/fl; Wnt1-Cre, Spry1;Wnt1-Cre
have defects in differentiation. Spry1;Wnt1-Cre mice also
share phenotypic similarities to Alk5fl/fl; Wnt1-Cre mice
including cardiac defects [31] and craniofacial defects
including cleft palate [32]. The Alk5fl/fl; Wnt1-Cre cranio-
facial defects are more severe in that they lack nasal and
frontal bones and, parietal bones, whereas Spry1;Wnt1-
Cre  embryos lacked frontal and nasal bones but had
nearly normal parietal bones. Whether Spry1 directly
influences PDGFRα and Alk5 signaling in NCC directly
will require further study.
Forced expression of Spry1 in Wnt1-expressing cells
was also associated with defects in the development of
cranial nerves including the glossopharyngeal nerve (IX)
and the vagus nerve (X). Hypoplastic and patterning
abnormalities of cranial nerves was revealed by immu-
nostaining with neurofilament antibodies. Migrating
Sox-10-expressing NCC contribute to cranial nerves IX
and X, and these cells are reduced and their migration
and guidance are defective in Hox3a-/-[33], Fbln1-/-[34],
and Msx1-/-;Msx2-/- mice. It is likely the defects in cranial
nerves in Spry1;Wnt1-Cre embryos are due to a combina-
tion of reduced NCC proliferation or survival or altered
responses to local guidance cues due to forced expression
of Spry1.
Spry1;Wnt1-Cre embryos die perinatally due to cranio-
facial and cardiac defects including persistent truncus
arteriosus and aortic pulmonary trunk abnormalities.
Fate mapping studies using Spry1;R26R;Wnt1-Cre mice
show that NCC correctly migrate into the branchial
arches. It is likely that NCC insufficiency due to
decreased proliferation and increased apoptosis in this
region is the cause for the failure of formation of the aor-
ticopulmonary septum, resulting in an overriding truncus
arteriosus and DORV.
Conclusion
Our results show that Spry1 is expressed in neural crest
and neural crest derived craniofacial structures. Forced
expression of Spry1 in Wnt1-Cre expressing cells resulted
craniofacial and cardiac defects. Our data and that of oth-
ers suggest that appropriate Spry1 levels are important to
correct patterning of neural crest derived structures
including bones of the face and the cardiac outflow tract.
The similarity of the Spry1;Wnt1-Cre embryonic pheno-
type to the phenotypes of Pdgfrαfl/fl; Wnt1-Cre are consis-
tent with Spry1 inhibiting signaling downstream of RTKs.
The similarity of the Spry1;Wnt1-Cre embryonic pheno-
type to that of Alk5fl/fl; Wnt1-Cre embryos suggests a pos-
sible interaction of Spry1 with the Alk5 pathway.
Methods
Generation of Spry1;Wnt1-Cre mutant mice
Wnt1-Cre transgenic mice and R26R reporter mice have
been described previously [29]. The generation of CAG-Yang et al. BMC Developmental Biology 2010, 10:48
http://www.biomedcentral.com/1471-213X/10/48
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GFP-Spry1 transgenic mice has been described elsewhere
[21]. Briefly, the mouse Spry1 open reading frame was
tagged with a myc/his epitope and cloned into the CAG-
loxP-GFP-loxP vector (gift of J. Yoon). Transgenic mice
were generated by pronuclear injection of the linearized
p l a s m i d ,  a n d  t r a n s g e n i c  m i c e  s c r e e n e d  b y  P C R  o f
genomic DNA with GFP specific primers. The resulting
transgenic mice were designated CAGGFP-Spry1. This
transgenic line was maintained on a FVB genetic back-
ground. For lineage tracer analysis, CAGGFP-Spry1 mice
were crossed with R26R mice. Mice that were positive for
both GFP and β-galactosidase were then crossed with
Wnt1-Cre mice. These mice carry CNC cells labeled with
β-galactosidase before CNC cells begin to migrate out of
the neural tube [29]. Additional Spry1 expression studies
were performed on Spry1lacZ/+ mice were obtained from
the Mutant Mouse Regional Resource, University of Cali-
fornia, Davis, and recently described [35]. Detection of β-
galactosidase activity (β-gal) activity on whole embryos
and tissue sections was carried by using standard proce-
dures [21]. To over express Spry1 in neural crest cells
CAGGFP-Spry1 mice were crossed with Wnt1-Cre mice,
and double transgenic mic e were identified by PCR of
genomic DNA from either tails or placenta using specific
primer for GFP and Cre.
All mice were housed in a pathogen-free environment,
under light, temperature, and humidity controlled condi-
tions. The Maine Medical Center Research Institute
Institutional Animal Care and Use Committee approved
all procedures involving animals.
Skeletal preparations
Skeletal preparations were performed as described [29].
Briefly, timed pregnant females or newborn mice were
euthanized by asphyxiation in CO2. Embryos and neo-
nates were skinned, eviscerated, and fixed in 95% ethanol.
The skeletons were stained with alcian blue, cleared in 1%
KOH, and counterstained with alizarin red.
Magnetic resonance imaging
Magnetic resonance (MR) images were obtained with a
BRUKER PharmaScan 7 T, 300 MHz scanner using a
RARE 8 pulse sequence with the following parameters:
TE 39.8 ms, TR 2571 ms, FOV 35 × 35 mm, Matrix 256 ×
256, Slice 1 mm (total of 7 slices), 3 averages, total scan
time 4 min 6 sec. Pregnant female mice were maintained
under anesthesia using 2% isoflurane, a slightly higher
percentage than used in other scans to minimize embry-
onic movement and to allow non-breathing gated image
acquisition. The total anesthesia time was less than 30
min and the pregnant females recovered normally from
the procedure. The orientation of the image slices was
chosen such that two embryos could be imaged in the
sagittal view.
Histology and in situ hybridization
For histological analysis, embryos were fixed in 4% para-
formaldehyde, and were either embedded in OCT, and
serial 7 μm-frozen sections were prepared, or embryos
were embedded in paraffin and sectioned using standard
procedures. For general morphology, deparaffinized sec-
tions were stained with hematoxylin and eosin using
standard procedures.
For whole-mount in situ hybridization, plasmids were
linearized with appropriate restriction enzyme; digoxy-
genin-labeled riboprobes were generated using a kit
(Roche) according to manufacturer's protocol. Fgf8 probe
was from P.H. Crossley, Msx1, Msx2, Dlx5, and Dlx6 were
from Yang Chai, AP-2 was from Trevor Williams. In situ
hybridization was processed according to established
protocols. Briefly, embryos were washed with PTW (PBS
+ 0.1% Tween-20), treated with 10 μg/ml proteinase K
briefly, prehybridized at 65°C, hybridized with indicated
antisense probe at 65°C for overnight, then detected with
alkaline phosphatase-conjugated anti-digoxygenin anti-
body (Roche), and developed with BM purple (Roche).
X-gal Staining
Mouse embryos at E9.5 or E10.5 were fixed in 4% para-
formaldehyde for 10 mins, washed in PBS, and stained in
X-gal solution at 37°C overnight. After staining, embryos
were refixed and embedded in either OCT or paraffin; 7
μm cryostat sections were taken for microscopic analysis.
Proliferation and apoptosis assays
Embryos were collected at E9.5 or E10.5, fixed in 4%
paraformaldehyde and embedded in OCT, and serial 7
μm sections were prepared for proliferation or apoptosis
analysis. Immunofluorescent staining using anti-phos-
phor-Histone3 (Ser10) antibody (Upstate) was per-
formed, phosphor-H3 positive cell was quantified and the
proliferation rates were expressed as a percentage of total
cells. For TUNEL labeling, the fluorescent in situ Cell
Death Detection kit (Roche) was used according to the
manufacturer's instructions, and the number of apoptotic
cells per section was quantified.
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